Literature DB >> 16461989

Pathophysiology of urticaria.

Ana Hennino1, Fréderic Bérard, Isabelle Guillot, Nathalie Saad, Auore Rozières, Jean-François Nicolas.   

Abstract

Urticaria is dermal edema resulting from vascular dilatation and leakage of fluid into the skin in response to molecules released from mast cells. The major preformed mediator histamine produces a prototypic, short-lived urticaria. However, the clinical spectrum and pattern of lesions indicate that other molecules, including prostaglandins, leukotrienes, cytokines, and chemokines, produced at different times after mast cell activation contribute to the polymorphism of this symptom and the variable evolution of this disease. It is a common practice to distinguish immunological and nonimmunological urticaria. Immunological urticaria is a hypersensitivity reaction mediated by antibodies and/or T-cells that results in mast cell activation. Although immunoglobulin (Ig)E-mediated type I hypersensitivity (HS) was long postulated to be the major immunological pathway associated with mast cell activation, interaction between IgE-bound mast cells and allergens is unlikely to be the mechanism by which urticaria develops in most patients. It is now well established that urticaria may result from the binding of IgG auto-antibodies to IgE and/or to the receptor for IgE molecules on mast cells, thus corresponding to a type II HS reaction. These auto-immune urticarias represent up to 50% of patients with chronic urticaria. Mast cell activation can also result from type III HS through the binding of circulating immune complexes to mast cell-expressing Fc receptors for IgG and IgM. Finally, under certain circumstances, T-cells can induce activation of mast cells, as well as histamine release (type IV HS). Nonimmunological urticarias result from mast cell activation through membrane receptors involved in innate immunity (e.g., complement, Toll-like, cytokine/chemokine, opioid) or by direct toxicity of xenobiotics (haptens, drugs). In conclusion, urticaria may result from different pathophysiological mechanisms that explain the great heterogeneity of clinical symptoms and the variable responses to treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461989     DOI: 10.1385/CRIAI:30:1:003

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  35 in total

Review 1.  Negative regulation of hematopoietic cell activation and proliferation by Fc gamma RIIB.

Authors:  O Malbec; W H Fridman; M Daëron
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

2.  [Airborne allergen induced urticaria].

Authors:  J L Bourrain
Journal:  Ann Dermatol Venereol       Date:  2001-10       Impact factor: 0.777

Review 3.  [Immunological and non immunological mechanisms in urticaria].

Authors:  F Bérard; P Saint-Mezard; F Cousin; S Mecheri; J-F Nicolas
Journal:  Ann Dermatol Venereol       Date:  2003-05       Impact factor: 0.777

4.  Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation.

Authors:  N Inamura; Y A Mekori; S P Bhattacharyya; P J Bianchine; D D Metcalfe
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

Review 5.  Signal transduction by Fc receptors: the Fc epsilon RI case.

Authors:  M A Beaven; H Metzger
Journal:  Immunol Today       Date:  1993-05

6.  Persistent urticaria--urticarial reaction caused by late phase reaction?

Authors:  A Kitao; S Nobuhara; S Kore-Eda; K Takahashi; C Nishigori; Y Miyachi
Journal:  Eur J Dermatol       Date:  2001 Sep-Oct       Impact factor: 3.328

7.  Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes.

Authors:  D Skokos; S Le Panse; I Villa; J C Rousselle; R Peronet; B David; A Namane; S Mécheri
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.

Authors:  M L Pacor; G Di Lorenzo; R Corrocher
Journal:  Clin Exp Allergy       Date:  2001-10       Impact factor: 5.018

9.  Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact.

Authors:  S P Bhattacharyya; I Drucker; T Reshef; A S Kirshenbaum; D D Metcalfe; Y A Mekori
Journal:  J Leukoc Biol       Date:  1998-03       Impact factor: 4.962

10.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.

Authors:  R Malaviya; T Ikeda; E Ross; S N Abraham
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

View more
  26 in total

1.  Association of Blastocystis hominis genetic subtypes with urticaria.

Authors:  Dina M Abdel Hameed; Omayma M Hassanin; Nehal Mohamed Zuel-Fakkar
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

2.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

3.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 4.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

Review 5.  Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite.

Authors:  Dinesh Giri Goswami; Rajesh Agarwal; Neera Tewari-Singh
Journal:  Toxicol Lett       Date:  2017-11-12       Impact factor: 4.372

Review 6.  Autoimmunity and complement in the pathogenesis of chronic urticaria.

Authors:  Alexander M Marsland
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

7.  The hidden impact of different Blastocystis genotypes on C-3 and IgE serum levels: a matter of debate in asthmatic Egyptian children.

Authors:  Enas A El Saftawy; Noha M Amin; Dina H Hamed; Aly Elkazazz; Sherihan Adel
Journal:  J Parasit Dis       Date:  2019-03-30

Review 8.  Rupatadine: a review of its use in the management of allergic disorders.

Authors:  Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Allergy and the skin.

Authors:  C Incorvaia; F Frati; N Verna; S D'Alò; A Motolese; S Pucci
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 10.  Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis.

Authors:  Shao-Heng He; Hui-Yun Zhang; Xiao-Ning Zeng; Dong Chen; Ping-Chang Yang
Journal:  Acta Pharmacol Sin       Date:  2013-08-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.